232 related articles for article (PubMed ID: 17703217)
21. Delivery of nucleic acids with a stearylated (RxR)4 peptide using a non-covalent co-incubation strategy.
Lehto T; Abes R; Oskolkov N; Suhorutsenko J; Copolovici DM; Mäger I; Viola JR; Simonson OE; Ezzat K; Guterstam P; Eriste E; Smith CI; Lebleu B; Samir El Andaloussi ; Langel U
J Control Release; 2010 Jan; 141(1):42-51. PubMed ID: 19744531
[TBL] [Abstract][Full Text] [Related]
22. Gateways and tools for drug delivery: endocytic pathways and the cellular dynamics of cell penetrating peptides.
Jones AT
Int J Pharm; 2008 Apr; 354(1-2):34-8. PubMed ID: 18068916
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA).
Bendifallah N; Rasmussen FW; Zachar V; Ebbesen P; Nielsen PE; Koppelhus U
Bioconjug Chem; 2006; 17(3):750-8. PubMed ID: 16704214
[TBL] [Abstract][Full Text] [Related]
24. Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery.
Mäe M; Langel U
Curr Opin Pharmacol; 2006 Oct; 6(5):509-14. PubMed ID: 16860608
[TBL] [Abstract][Full Text] [Related]
25. Applications of cell-penetrating peptides in regulation of gene expression.
Järver P; Langel K; El-Andaloussi S; Langel U
Biochem Soc Trans; 2007 Aug; 35(Pt 4):770-4. PubMed ID: 17635145
[TBL] [Abstract][Full Text] [Related]
26. In vivo biodistribution and efficacy of peptide mediated delivery.
Järver P; Mäger I; Langel Ü
Trends Pharmacol Sci; 2010 Nov; 31(11):528-35. PubMed ID: 20828841
[TBL] [Abstract][Full Text] [Related]
27. Intracellular delivery of oligonucleotide conjugates and dendrimer complexes.
Juliano RL
Ann N Y Acad Sci; 2006 Oct; 1082():18-26. PubMed ID: 17145920
[TBL] [Abstract][Full Text] [Related]
28. Cell-penetrating peptides: Nanocarrier for macromolecule delivery in living cells.
Chugh A; Eudes F; Shim YS
IUBMB Life; 2010 Mar; 62(3):183-93. PubMed ID: 20101631
[TBL] [Abstract][Full Text] [Related]
29. Splice-switching efficiency and specificity for oligonucleotides with locked nucleic acid monomers.
Guterstam P; Lindgren M; Johansson H; Tedebark U; Wengel J; El Andaloussi S; Langel U
Biochem J; 2008 Jun; 412(2):307-13. PubMed ID: 18271753
[TBL] [Abstract][Full Text] [Related]
30. A stearylated CPP for delivery of splice correcting oligonucleotides using a non-covalent co-incubation strategy.
Mäe M; El Andaloussi S; Lundin P; Oskolkov N; Johansson HJ; Guterstam P; Langel U
J Control Release; 2009 Mar; 134(3):221-7. PubMed ID: 19105971
[TBL] [Abstract][Full Text] [Related]
31. The use of cell-penetrating peptides as a tool for gene regulation.
Järver P; Langel U
Drug Discov Today; 2004 May; 9(9):395-402. PubMed ID: 15081956
[TBL] [Abstract][Full Text] [Related]
32. Comparison of cellular uptake using 22 CPPs in 4 different cell lines.
Mueller J; Kretzschmar I; Volkmer R; Boisguerin P
Bioconjug Chem; 2008 Dec; 19(12):2363-74. PubMed ID: 19053306
[TBL] [Abstract][Full Text] [Related]
33. Translocation or membrane disintegration? Implication of peptide-membrane interactions in pep-1 activity.
Henriques ST; Castanho MA
J Pept Sci; 2008 Apr; 14(4):482-7. PubMed ID: 18181239
[TBL] [Abstract][Full Text] [Related]
34. Cellular internalization kinetics of (luciferin-)cell-penetrating peptide conjugates.
Eiríksdóttir E; Mäger I; Lehto T; El Andaloussi S; Langel U
Bioconjug Chem; 2010 Sep; 21(9):1662-72. PubMed ID: 20684543
[TBL] [Abstract][Full Text] [Related]
35. Chemically modified cell-penetrating peptides for the delivery of nucleic acids.
Mäe M; Andaloussi SE; Lehto T; Langel U
Expert Opin Drug Deliv; 2009 Nov; 6(11):1195-205. PubMed ID: 19831582
[TBL] [Abstract][Full Text] [Related]
36. Thermodynamic studies and binding mechanisms of cell-penetrating peptides with lipids and glycosaminoglycans.
Ziegler A
Adv Drug Deliv Rev; 2008 Mar; 60(4-5):580-97. PubMed ID: 18045730
[TBL] [Abstract][Full Text] [Related]
37. CPP-protein constructs induce a population of non-acidic vesicles during trafficking through endo-lysosomal pathway.
Räägel H; Säälik P; Hansen M; Langel U; Pooga M
J Control Release; 2009 Oct; 139(2):108-17. PubMed ID: 19577599
[TBL] [Abstract][Full Text] [Related]
38. Live-cell analysis of cell penetration ability and toxicity of oligo-arginines.
Tünnemann G; Ter-Avetisyan G; Martin RM; Stöckl M; Herrmann A; Cardoso MC
J Pept Sci; 2008 Apr; 14(4):469-76. PubMed ID: 18069724
[TBL] [Abstract][Full Text] [Related]
39. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides.
Gupta B; Levchenko TS; Torchilin VP
Adv Drug Deliv Rev; 2005 Feb; 57(4):637-51. PubMed ID: 15722168
[TBL] [Abstract][Full Text] [Related]
40. Cell transduction pathways of transportans.
Padari K; Säälik P; Hansen M; Koppel K; Raid R; Langel U; Pooga M
Bioconjug Chem; 2005; 16(6):1399-410. PubMed ID: 16287236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
